This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
These 2 Basic Materials Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Nutrien (NTR) Prices $1 Billion of 3-Year & 10-Year Senior Notes
by Zacks Equity Research
The senior notes will be unsecured and will rank on an equal footing with Nutrien's (NTR) current senior unsecured debt.
Zacks Industry Outlook Nutrien, ICL and Intrepid Potash
by Zacks Equity Research
Nutrien, ICL and Intrepid Potash have been highlighted in this Industry Outlook article.
3 Top Fertilizer Stocks to Watch From a Promising Industry
by Anindya Barman
Favorable demand in major markets for crop nutrients, backed by the strength in global agriculture markets, should enable the Zacks Fertilizers industry to thrive. NTR, ICL and IPI should benefit from supportive industry fundamentals.
Nutrien (NTR) Down 4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nutrien (NTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Samsara's (IOT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Samsara's (IOT) fiscal first-quarter performance benefits from expanding its customer base.
Here's Why You Should Retain Nutrien (NTR) in Your Portfolio
by Zacks Equity Research
While Nutrien (NTR) is exposed to pricing pressure, it benefits from solid demand for fertilizers, backed by the strength in global agriculture markets.
Nutrien (NTR) Shares Pop 15% in 3 Months: What's Driving It?
by Zacks Equity Research
Nutrien (NTR) gains on strong demand for crop nutrients on the strength in global agriculture markets and its cost and operational efficiency initiatives.
Nutrien (NTR) Gains on Demand Strength Amid Pricing Headwinds
by Zacks Equity Research
While Nutrien (NTR) is exposed to pricing pressure, it benefits from solid demand for fertilizers, backed by the strength in global agriculture markets.
Sociedad Quimica (SQM) Earnings and Sales Top Estimates in Q1
by Zacks Equity Research
Sociedad Quimica (SQM) beats first-quarter estimates on higher sales volumes amid headwinds from lower prices.
Intrepid Potash (IPI) Q1 Earnings Lag, Sales Beat Estimates
by Zacks Equity Research
Lower revenues in the Potash segment weigh on Intrepid Potash's (IPI) first-quarter top line.
Nutrien's (NTR) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Nutrien's (NTR) first-quarter earnings and sales beat the respective estimates amid lower average selling prices.
Compared to Estimates, Nutrien (NTR) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Nutrien (NTR) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Nutrien (NTR) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nutrien (NTR) delivered earnings and revenue surprises of 27.78% and 0.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Wall Street's Insights Into Key Metrics Ahead of Nutrien (NTR) Q1 Earnings
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Nutrien (NTR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
Analysts Estimate ICL Group (ICL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
ICL Group (ICL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Nutrien (NTR) Q1 Earnings Expected to Decline
by Zacks Equity Research
Nutrien (NTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Badger Meter and Nutrien have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Badger Meter and Nutrien have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: Nutrien (NTR)
by Derek Lewis
Analysts' negative earnings estimate revisions paint a challenging picture for the company's shares in the near term.
Nutrien (NTR) Gains on Strong Demand Amid Pricing Woes
by Zacks Equity Research
While Nutrien (NTR) faces pricing headwinds, it benefits from solid demand for fertilizers, backed by the strength in global agriculture markets.
Here's Why You Should Retain Nutrien (NTR) in Your Portfolio
by Zacks Equity Research
While Nutrien (NTR) faces challenges from softer fertilizer prices, it gains on strong demand for crop nutrients on the strength in global agriculture markets.
How to Boost Your Portfolio with Top Basic Materials Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Nutrien (NTR) Down 1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nutrien (NTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nutrien (NTR) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Nutrien (NTR) stood at $53.09, denoting a -1.1% change from the preceding trading day.
Is It Worth Investing in Nutrien (NTR) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Nutrien (NTR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?